Twenty Years In Early Stage Biotech VC (Part 1): Science

In the blink of an eye, twenty years have passed: in mid-October 2005, I joined Atlas Venture as a principal on the global life science team.  We closed Fund VII a few months after I joined; and, just a few weeks ago, we closed our 11^th fund since then with Opportunity Fund III. What a journey.

Like the world, biotech has changed dramatically since 2005. So has Atlas. Over the course of the first nine years after joining, we retooled ourselves from a global multi-office, multi-sector firm into a biotech-only VC based in Cambridge MA.  Simplicity and focus are beautiful.

Since joining Atlas, I’ve worked with scores of biotech companies as…